Have one to sell? Sell yours here
Principles of Tissues Engineering
  
Tell the Publisher!
I'd like to read this book on Kindle

Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.

Principles of Tissues Engineering [Hardcover]

R. P. Lanza (Editor), Robert S. Langer (Editor), William L. Chick (Editor)
3.8 out of 5 stars  See all reviews (5 customer reviews)


Available from these sellers.


Formats

Amazon Price New from Used from
Hardcover --  
Hardcover, June 1997 --  

Book Description

June 1997
Tissue engineering is a rapidly growing area of biomedical research with obvious commercial applications. This is a comprehensive, definitive text-reference which will become the benchmark in this area. Principles in Tissue Engineering strikes a balance among the diversity of subjects that are related to tissue engineering, including biology, chemistry, material science, engineering, immunology, and transplantation, while emphasizing those research areas that are likely to be of the most value to medicine in the future.

This book represents the combined intellect of almost 100 scholars and clinicians who's pioneering work has been instrumental to ushering in this fascinating and important field.


Key Features

* Coverage is comprehensive yet succinct
* Emphasizes research areas that are likely to be of the most value to medicine in the future
* Topics covered include biology, chemistry, material science, engineering, immunology, and transplantation aspects of tissue engineering
--This text refers to an out of print or unavailable edition of this title.

Customers Who Bought This Item Also Bought


Editorial Reviews

Review

"[the book] is vast, detailed, and beautifully presented...one cannot but be impressed...."
--NATURE

"This new treatise on the principles of tissue engineering is essential for anyone working in the field. It is a vast, detailed and beautifully presented analysis of the cellular principles, in vitro and in vivo<$? behavior, modeling and applications of tissue engineering...The coverage of the subjects is detailed and clearly annotated..With a book this size, one cannot but be impressed by its coverage...the book achieves its main goal of educating and directing the novice and advanced researcher in the field."
--Nicholas A. Peppas in NATURE

"There is no comparison...Co-editor Bob Langer is the top person in the entire field....This book looks like an excellent one."
--PRINCETON UNIVERSITY --This text refers to an out of print or unavailable edition of this title.

From the Back Cover

The first edition of Principles of Tissue Engineering, published in 1997, was rapidly recognized as the definitive reference in the field. Since that time, the discipline has grown tremendously, and few experts could have predicted the explosion in the knowledge of gene expression, cell growth and differentiation, the variety of stem cells and new polymers, or even the successful introduction of the first tissue-engineered products into the marketplace. Principles of Tissue Engineering, Second Edition defines and captures the evolution of this fascinating and exciting field. This comprehensive reference covers the prerequisites for a general understanding of tissue growth and development, the tools and theoretical information needed to design tissues and organs, and the applications of tissue engineering to diseases affecting organ systems.
Key Features
* Essential to anyone working in the field
* Vast, detailed analysis of research with all of the major systems of the human body, e.g., skin, muscle, cardiovascular, hematopoietic, and nerves
* Contributions by leaders in the latest areas of research, such as fetal tissue engineering and stem cells --This text refers to an out of print or unavailable edition of this title.

Product Details

  • Hardcover: 808 pages
  • Publisher: Academic Pr (June 1997)
  • Language: English
  • ISBN-10: 1570593426
  • ISBN-13: 978-1570593420
  • Average Customer Review: 3.8 out of 5 stars  See all reviews (5 customer reviews)

More About the Author

Dr. Robert Lanza is Chief Scientific Officer at Advanced Cell Technology, and Adjunct Professor at Wake Forest University School of Medicine. He has hundreds of publications and inventions, and over two dozen scientific books: among them, "Principles of Tissue Engineering," which is recognized as the definitive reference in the field. Others include One World: The Health & Survival of the Human Species in the 21st Century (Foreword by former President Jimmy Carter), and the "Handbook of Stem Cells" and "Essentials of Stem Cell Biology," which are considered the definitive references in stem cell research.

Dr. Lanza received his BA and MD degrees from the University of Pennsylvania, where he was both a University Scholar and Benjamin Franklin Scholar. He was also a Fulbright Scholar, and was part of the team that cloned the world's first human embryo for the purpose of generating embryonic stem cells. Dr. Lanza's work has been crucial to our understanding nuclear transfer and stem cell biology. In 2001 he was also the first to clone an endangered species (a Gaur), and in 2003, he cloned an endangered wild ox (a Banteng) from the frozen skin cells of an animal that had died at the San Diego Zoo nearly a quarter-of-a-century earlier. Lanza and his colleagues were also the first to demonstrate that nuclear transplantation could be used to reverse the aging process and to generate immune-compatible tissues, including the first organ tissue-engineered from cloned cells. One of his greatest early achievements came from his demonstration that techniques used in preimplantation genetic diagnosis could be used to generate human embryonic stem (hES) cells without embryonic destruction.

Lanza and colleagues have also succeeded in differentiating human pluripotent stem cells into retinal (RPE) cells, and has shown that they provide long-term benefit in animal models of vision loss. Using this technology some forms of blindness may be curable, including macular degeneration and Stargardt disease, a currently untreatable form eye disease that causes blindness in teenagers and young adults. Lanza's company (ACT) received FDA approval to begin clinical trials using them to treat degenerative eye diseases. These two clinical trials began in July 2011. Recently, ACT received similar approval for the first human embryonic stem cell trial in Europe.

Lanza has been a major player in the scientific revolution that has led to the documentation that nuclear transfer/ transcription factors can restore developmental potential in a differentiated cell. One of his recent successes was showing that it is feasible to generate functional oxygen-carrying red blood cells from human embryonic stem cells. The blood cells were comparable to normal transfusable blood and could serve as a potentially inexhaustible source of "universal" blood. His team also discovered how to generate functional hemangioblasts - a population of "ambulance" cells- from hES cells. In animals, these cells quickly repaired vascular damage, cutting the death rate after a heart attack in half and restoring the blood flow to ischemic limbs that might otherwise have to be amputated. Recently, Lanza and a team lead by Kwang-Soo Kim at Harvard University reported a safe method for generating induced pluripotent stem (iPS) cells. Human iPS cells were created from skin cells by direct delivery of proteins, thus eliminating the harmful risks associated with genetic manipulation. This new method provides a potentially safe source of patient-specific stem cells for translation into the clinic. The Editors of the prestigious journal Nature selected Lanza and Kim's paper on protein reprogramming as one of five "Research Highlights" of 2009. Discover magazine stated, "Lanza's single-minded quest to usher in this new age has paid dividends in scientific insights and groundbreaking discoveries."

Dr. Lanza has received numerous awards, including an NIH Director's Award (2010) for "Translating Basic Science Discoveries into New and Better Treatments"; the 2010 'Movers and Shakers' Who Will Shape Biotech Over the Next 20 Years (BioWorld)(along with Craig Venter and President Barack Obama); the 2007 100 Most Inspiring People in the Life-Sciences Industry (PharmaVOICE, "For his discoveries 'behind the medicines making a significant impact on the pipelines of today and of the future'"; the 2007 Outstanding Contribution in Contemporary Biology Award (Brown University, "For his groundbreaking research and contributions in stem cell science and biology"; the 2006 All-Star Award for Biotechnology (MA High Tech, for "pushing stem cells' future"); the 2005 Rave Award for Medicine (Wired magazine, "For eye-opening work on embryonic stem cells"); and Lanza is listed in Who's Who in America, Who's Who in the World, Who's Who in Medicine and Healthcare, Who's Who in Science and Engineering; Who's Who in American Education, and Who's Who in Technology, among others. Dr. Lanza has served in numerous national and international leadership capacities, including Conference Co-Chairman, International Symposium on Stem Cells (Tianjin, China 2008); Stem Cell Advisory Committee, International Stem Cell Registry; He has given keynote addresses at dozens of national and international societies, including ASAIO (2001), Annual Molecular & Cellular Biology Symposium (2002), Biotechniques Live/Drug Discovery Technology & Development World Congress (2005), International Stem Cell Conference (2007), Tissue Engineering & Regenerative Medicine International Society (TERMIS)(2007), Translational Regenerative Medicine Forum (2010), among others.

Dr. Lanza and his research have been featured in almost every media outlet in the world, including CNN, TIME, Newsweek, People, as well as the front pages of the New York Times, Wall Street Journal, Washington Post, among others. Lanza has worked with some of the greatest thinkers of our time, including Nobel laureates Gerald Edelman and Rodney Porter, renowned Harvard psychologist B.F. Skinner (the "Father of modern behaviorism"), Jonas Salk (discoverer of the Polio vaccine), and heart transplant pioneer Christiaan Barnard. His current research and work at Advanced Cell Technology focuses on stem cells and regenerative medicine and their potential to provide therapies for some of the world's most deadly and debilitating conditions.

In 2007, Lanza published a feature article, "A New Theory of the Universe" in The American Scholar, a leading intellectual journal which has previously published works by Albert Einstein, Margaret Mead, and Carl Sagan, among others. His theory places biology above the other sciences in an attempt to solve one of nature's biggest puzzles, the theory of everything that other disciplines have been pursuing for the last century. This new view has become known as Biocentrism. In 2009, he co-authored a book "Biocentrism: How Life and Consciousness are the Keys to Understanding the True Nature of the Universe" with leading astronomer Bob Berman. In biocentrism, space and time are forms of animal sense perception, rather than external physical objects. Understanding this more fully yields answers to several major puzzles of mainstream science, and offers a new way of understanding everything from the microworld (for instance, the reason for Heisenberg's uncertainty principle and the double-slit experiment) to the forces, constants, and laws that shape the universe. Nobel laureate E. Donnall Thomas stated "Any short statement does not do justice to such a scholarly work. The work is a scholarly consideration of science and philosophy that brings biology into the central role in unifying the whole."

You can read more about Dr. Robert Lanza's work at:

http://www.robertlanza.com/
http://www.robertlanzabiocentrism.com/
http://www.advancedcell.com/company/leadership-team/senior-executive-officers/

 

Customer Reviews

5 Reviews
5 star:
 (2)
4 star:
 (1)
3 star:
 (1)
2 star:
 (1)
1 star:    (0)
 
 
 
 
 
Average Customer Review
3.8 out of 5 stars (5 customer reviews)
 
 
 
 
Share your thoughts with other customers:
Most Helpful Customer Reviews

3 of 3 people found the following review helpful:
5.0 out of 5 stars Excellent reference, November 12, 2000
By A Customer
A few too many equations, but clearly the most comprehensive text in the field. Contributors list reads like a 'Who's Who' of tissue engineering.
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No


2 of 3 people found the following review helpful:
5.0 out of 5 stars Excellent textbook for students and researchers, December 2, 2000
By A Customer
A vast, detailed summary of the latest advances in tissue engineering.
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No


4 of 4 people found the following review helpful:
4.0 out of 5 stars Covering the whole body, September 28, 2001
By 
Peter Bernstein (Tübingen, Germany) - See all my reviews
This is a great book, covering most details of its field. It describes the physicians (and their patients) dream of substituting organs and cells and it also shows, how mankind could not solve problems  up to now. History of artificial organs lacking the full function is one point, but the focus is on cells and their ability to build complete organs  and therefore the book looks on the pathway for the future of organ substitution.
The introduction covers some main ideas of tissue engineering  what do we want  what are we able to do  what do we still have to get knowledge of. After a short review of the history, the essentials of cell biology (Growth, Differentiation) are being introduced. The reader should have an idea of developmental biology to be able to follow topics like induction and morphogenesis. The authors emphasize the importance of the extracellular matrix as one of organ-prosthesis main building blocks (ECM = scaffold; cells = function; cell signalling = integration and physiology).
The second part describes technical aspects of in-vitro organ synthesis: tissue culture and ECM, tissue culture und growth factors, bioreactors and vascularization. The third part continues with in-vivo techniques of organ reparation, exemplified by methods for substitution of the ECM of skin, peripheral nerves and meniscus.
Parts 4  6 develop models for the substitution of the ECM (Collagen, BioPolymers), their implantation in the receiving organism and the resulting immunologic problems (emphasized).
Parts 7  20 are concerned with the organs themselves. After few words about stem cells and gene therapy the book explains reconstruction and substitution methods for breast, heart and blood vessels, Cornea, endocrine glands, liver (very good), kidney and haematopoietic system. Biomechanical problems are outlined in the part about the musculoskeletal system. On this place tissue engineering celebrates its oldest success (cartilage substitution). Today innervation processes are being focused.
The book continues with substitutes for the senses (ear and eye), nerve cells, nerve regeneration and neural stem cells. Dents and skin could be all to make an ill patient healthy by substitutes, one might think. But no, western medicine also knows something about substitutes for womb and placenta
On me the book made a good impression. The only point is: its quite too much text and too few pictures. It addresses medicals after their exams, practicing physicians and biologists. Chapters focus on the basic principles. There is a large number of links to more detailed publications.
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No

Share your thoughts with other customers: Create your own review
 
 
 
Most Recent Customer Reviews



Only search this product's reviews



Inside This Book (learn more)
Browse and search another edition of this book.
First Sentence:
During the past decade-in fact, since the publication of the first edition of this book in 1997 - the field of tissue engineering has grown at a seemingly logarithmic rate. Read the first page
Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
stroma cell lines, neointestinal mucosa, fetal tissue engineering, encapsulated bovine chromaffin cells, first allotransplantation, lymphoid precursor cells, immunobarrier devices, parathyroid allotransplantation, reparative dentinogenesis, persistent hypoparathyroidism, osteocytic processes, situ oxygen generation, following deafness, designer tissues, matricellular proteins, immune acceptance, platelet disposition, tissue engineering bioreactors, hexadecane thiol, encapsulated cell therapy, cyclic traction, cartilaginous constructs, exstrophic bladder, fetal cell lines, potential bioartificial liver
Key Phrases - Capitalized Phrases (CAPs): (learn more)
New York, Brain Res, United States, Cell Res, Cell Sci, Tissue Eng, Visual Sci, San Diego, Cancer Res, Artif Organs, Deu Biol, Boca Raton, Manuela Martins-Green, Raven Press, Sports Med, Advanced Tissue Sciences, National Institutes of Health, Vickery Trinkaus-Randall, Humana Press, John Wiley, Cold Spring Harbor, Genes Deu, Genes Dev, Oral Biol, The Netherlands
New!
Books on Related Topics | Concordance | Text Stats
Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Surprise Me!
Search Inside This Book:


What Other Items Do Customers Buy After Viewing This Item?


Suggested Tags from Similar Products

 (What's this?)
Be the first one to add a relevant tag (keyword that's strongly related to this product).
 
(9)

Your tags: Add your first tag
 

Sell a Digital Version of This Book in the Kindle Store

If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store. Learn more

Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   
Related forums


So You'd Like to...


Create a guide


Look for Similar Items by Category


Look for Similar Items by Subject

Search Books by subject:






i.e., each book must be in subject 1 AND subject 2 AND ...